Two Sigma Advisers’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-605,300
Closed -$22.8M 2824
2021
Q1
$22.8M Buy
605,300
+12,400
+2% +$467K 0.06% 329
2020
Q4
$10.1M Buy
592,900
+160,200
+37% +$2.72M 0.03% 562
2020
Q3
$2.03M Buy
432,700
+25,200
+6% +$118K 0.01% 1156
2020
Q2
$2.49M Sell
407,500
-8,900
-2% -$54.3K 0.01% 1097
2020
Q1
$945K Buy
416,400
+53,000
+15% +$120K ﹤0.01% 1519
2019
Q4
$1.67M Buy
363,400
+162,800
+81% +$747K ﹤0.01% 1316
2019
Q3
$777K Buy
200,600
+14,300
+8% +$55.4K ﹤0.01% 1544
2019
Q2
$1.12M Buy
186,300
+34,200
+22% +$206K ﹤0.01% 1459
2019
Q1
$2.04M Sell
152,100
-34,000
-18% -$456K 0.01% 1217
2018
Q4
$1.73M Sell
186,100
-29,400
-14% -$273K ﹤0.01% 1239
2018
Q3
$3M Buy
215,500
+34,600
+19% +$482K 0.01% 1034
2018
Q2
$2.86M Sell
180,900
-15,000
-8% -$237K 0.01% 1131
2018
Q1
$3.37M Buy
195,900
+132,300
+208% +$2.27M 0.01% 1011
2017
Q4
$1.39M Buy
63,600
+56,100
+748% +$1.23M ﹤0.01% 1405
2017
Q3
$307K Sell
7,500
-200
-3% -$8.19K ﹤0.01% 1923
2017
Q2
$232K Sell
7,700
-4,700
-38% -$142K ﹤0.01% 2077
2017
Q1
$448K Buy
12,400
+700
+6% +$25.3K ﹤0.01% 1944
2016
Q4
$586K Sell
11,700
-33,700
-74% -$1.69M ﹤0.01% 1787
2016
Q3
$2.38M Buy
45,400
+38,400
+549% +$2.02M 0.01% 960
2016
Q2
$289K Sell
7,000
-14,900
-68% -$615K ﹤0.01% 1731
2016
Q1
$890K Buy
+21,900
New +$890K 0.01% 1173
2015
Q3
Sell
-8,600
Closed -$214K 2060
2015
Q2
$214K Sell
8,600
-5,500
-39% -$137K ﹤0.01% 1731
2015
Q1
$322K Buy
+14,100
New +$322K ﹤0.01% 1549